Drugs / ReCell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05386368 | Mar → Jul 2023 | — | Wake Forest University Health Sciences | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ReCell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05386368 ↗ |
| Modality | Cell therapy | “application of autologous cell suspension obtained via enzymatic and mechanical preparation” NCT05386368 ↗ |